Hey everyone, I've been closely following this thread and diving into pretty much everything available online about Verteporfin. This is my first time posting here, and I have some thoughts to share.
Firstly, Dr. Barghouthi, I believe I speak for everyone when I say a big thank you for your pioneering efforts in testing this treatment for the community. Your contributions have been absolutely crucial; without them, I doubt we would have even the faintest hint that this could be a viable solution.
I believe this thread is the longest in the forum not just because people are interested in finding solutions for their first hair transplant with long bald areas and limited donor supply. It's mainly because it gives hope to those who've had hair transplants and are now dealing with depleted donor areas. People such as myself feeling a bit lost because nothing currently available seems to fully solve this problem, and Verteporfin represents some hope.
It's funny how we often end up learning the most about something after making decisions, when ideally we should have done all the learning beforehand. But, well, there's no better motivation to learn than when you're trying to fix a problem.
I've read through all the suggestions for future trials, and, fundamentally, I believe that pretty much everything suggested is valid. Since none of us knows much about it beyond a basic understanding of its mechanism of action, all we can do is imagine possibilities and create hypotheses. So, I just want to share my opinion on that. And like any hypothesis, I might be wrong—actually, most likely I am.
I believe it's wise to hold off on testing verteporfin on the recipient area. I understand it sounds promising, but There are just too many extra variables, such as whether those follicles are resistant to DHT.
Instead, I suggest directing all the efforts towards scientifically determining if follicle regeneration is indeed possible.
Once we establish this, we can explore multiple possibilities of applications, and it's likely that attention to this will increase. Perhaps more investment and resources will come, and new possibilities will emerge.
These new possibilities, of course, could include getting new follicles from excising old FUE scars, which seems like the most promising outcome. Alternatively, transplanting freshly harvested follicles into those old FUE scars, essentially just moving them around within the donor area. If the original follicles partially or entirely regrow, we could achieve hair multiplication through multiple rounds, solely depending on the percentage of regenerated hair. But for me, this is all conversation for later.
Thanks to everyone for their contributions.
Last thing: I suggest adding the 🐐 emoji for reactions as a recognition of Barghouthi's efforts.